Drug Manufacturer Supply Options Could Be Constricted By Legislation
A more compact supply chain for pharmaceutical companies could result from congressional efforts to legislate greater emphasis on drug quality - both by FDA and by industry
A more compact supply chain for pharmaceutical companies could result from congressional efforts to legislate greater emphasis on drug quality - both by FDA and by industry